PDB Short entry for 1T1K
HEADER    HORMONE/GROWTH FACTOR                   16-APR-04   1T1K              
TITLE     NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-  
TITLE    2 B28-LYS, LYS-B29-PRO, 15 STRUCTURES                                  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: INSULIN;                                                   
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: INSULIN A CHAIN;                                           
COMPND   5 ENGINEERED: YES;                                                     
COMPND   6 MUTATION: YES;                                                       
COMPND   7 MOL_ID: 2;                                                           
COMPND   8 MOLECULE: INSULIN;                                                   
COMPND   9 CHAIN: B;                                                            
COMPND  10 FRAGMENT: INSULIN B CHAIN;                                           
COMPND  11 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE  
SOURCE   4 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS(HUMAN);            
SOURCE   5 MOL_ID: 2;                                                           
SOURCE   6 SYNTHETIC: YES;                                                      
SOURCE   7 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE  
SOURCE   8 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS(HUMAN)             
KEYWDS    ALA-B12-DKP-INSULIN, PROTEIN UNFOLDING, INSULIN RECEPTOR, RECEPTOR    
KEYWDS   2 BINDING, HORMONE-GROWTH FACTOR COMPLEX                               
EXPDTA    SOLUTION NMR                                                          
NUMMDL    15                                                                    
AUTHOR    K.HUANG,B.XU,S.Q.HU,Y.C.CHU,Q.X.HUA,J.WHITTAKER,S.H.NAKAGAWA,P.DE     
AUTHOR   2 MEYTS,P.G.KATSOYANNIS,M.A.WEISS                                      
REVDAT   3   27-OCT-21 1T1K    1       REMARK SEQADV                            
REVDAT   2   24-FEB-09 1T1K    1       VERSN                                    
REVDAT   1   10-AUG-04 1T1K    0                                                
JRNL        AUTH   K.HUANG,B.XU,S.Q.HU,Y.C.CHU,Q.X.HUA,Y.QU,B.LI,S.WANG,        
JRNL        AUTH 2 R.Y.WANG,S.H.NAKAGAWA,A.M.THEEDE,J.WHITTAKER,P.DE MEYTS,     
JRNL        AUTH 3 P.G.KATSOYANNIS,M.A.WEISS                                    
JRNL        TITL   HOW INSULIN BINDS: THE B-CHAIN ALPHA-HELIX CONTACTS THE L1   
JRNL        TITL 2 BETA-HELIX OF THE INSULIN RECEPTOR.                          
JRNL        REF    J.MOL.BIOL.                   V. 341   529 2004              
JRNL        REFN                   ISSN 0022-2836                               
JRNL        PMID   15276842                                                     
JRNL        DOI    10.1016/J.JMB.2004.05.023                                    
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   S.H.NAKAGAWA,H.S.TAGER,D.F.STEINER                           
REMARK   1  TITL   MUTATIONAL ANALYSIS OF INVARIANT VALINE B12 IN INSULIN:      
REMARK   1  TITL 2 IMPLICATION FOR RECEPTOR BINDING                             
REMARK   1  REF    BIOCHEMISTRY                  V.  39 15826 2000              
REMARK   1  REFN                   ISSN 0006-2960                               
REMARK   1  PMID   11123908                                                     
REMARK   1  DOI    10.1021/BI001802+                                            
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   C.KRISTEN,T.KJELDSEN,F.C.WIBERG,L.SCHAFFER,M.HACH,           
REMARK   1  AUTH 2 S.HAVELUND,J.BASS,D.F.STEINER,A.S.ANDERSEN                   
REMARK   1  TITL   ALANINE SCANNING MUTAGENESIS OF INSULIN                      
REMARK   1  REF    J.BIOL.CHEM.                  V. 272 12978 1997              
REMARK   1  REFN                   ISSN 0021-9258                               
REMARK   1  DOI    10.1074/JBC.272.20.12978                                     
REMARK   1 REFERENCE 3                                                          
REMARK   1  AUTH   Q.Q.WANG,Y.M.FENG,Y.S.ZHANG                                  
REMARK   1  TITL   STUDIES ON RECEPTOR BINDING SITE OF INSULIN: THE HYDROPHOBIC 
REMARK   1  TITL 2 B12VAL CAN BE SUBSTITUTED BY HYDROPHILIC THR                 
REMARK   1  REF    BIOCHEM.MOL.BIOL.INT.         V.  39  1245 1996              
REMARK   1  REFN                   ISSN 1039-9712                               
REMARK   1  PMID   9148904                                                      
REMARK   1  DOI    10.1074/JBC.272.20.12978                                     
REMARK   1 REFERENCE 4                                                          
REMARK   1  AUTH   S.Q.HU,G.T.BURKE,G.P.SCHWARTZ,N.FERDERIGOS,J.B.ROSS,         
REMARK   1  AUTH 2 P.G.KATSOYANNIS                                              
REMARK   1  TITL   STERIC REQUIRMENTS AT POSITION B12 FOR HIGH BIOLOGICAL       
REMARK   1  TITL 2 ACTIVITY IN INSULIN                                          
REMARK   1  REF    BIOCHEMISTRY                  V.  32  2631 1993              
REMARK   1  REFN                   ISSN 0006-2960                               
REMARK   1  PMID   8448120                                                      
REMARK   1  DOI    10.1021/BI00061A022                                          
REMARK   1 REFERENCE 5                                                          
REMARK   1  AUTH   G.P.SCHWARTZ,P.G.BURKE,P.G.KATSOYANNIS                       
REMARK   1  TITL   [12-ASPARAGINE-B] HUMAN INSULIN. AN ANALOGUE WITH            
REMARK   1  TITL 2 MODIFICATION IN THE HYDROPHOBIC CORE OF INSULIN              
REMARK   1  REF    INT.J.PEPT.PROTEIN RES.       V.  17   243 1981              
REMARK   1  REFN                   ISSN 0367-8377                               
REMARK   1  PMID   7014485                                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : DGII INSIGHTII 2000, X-PLOR 3.85                     
REMARK   3   AUTHORS     : MOLECULAR SIMULATIONS INC. (DGII), BRUNGER (X        
REMARK   3                 -PLOR)                                               
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL OF    
REMARK   3  668 RESTRAINTS: 607 ARE NOE-DERIVED DISTANCE CONSTRAINTS, 39 ARE    
REMARK   3  DIHEDRAL ANGLE RESTRAINTS, 22 ARE HYDROGEN BOND RESTRAINTS.         
REMARK   4                                                                      
REMARK   4 1T1K COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-APR-04.                  
REMARK 100 THE DEPOSITION ID IS D_1000022196.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298; 305; 298                      
REMARK 210  PH                             : 7.0; 7.6; 1.9                      
REMARK 210  IONIC STRENGTH                 : NULL; NULL; NULL                   
REMARK 210  PRESSURE                       : AMBIENT; AMBIENT; AMBIENT          
REMARK 210  SAMPLE CONTENTS                : 1.2 MM ALA-B12-DKP-INSULIN, 90%    
REMARK 210                                   H2O, 10% D2O; 1.2 MM ALA-B12-DKP-  
REMARK 210                                   INSULIN, 100% D2O; 1.2 MM ALA-     
REMARK 210                                   B12-DKP-INSULIN, 20% DEUTERATED    
REMARK 210                                   ACETIC ACID, 80% D2O               
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D NOESY; 2D TOCSY; DQF-COSY       
REMARK 210  SPECTROMETER FIELD STRENGTH    : 600 MHZ                            
REMARK 210  SPECTROMETER MODEL             : INOVA                              
REMARK 210  SPECTROMETER MANUFACTURER      : VARIAN                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : DISTANCE GEOMETRY AND SIMULATED    
REMARK 210                                   ANNEALING                          
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 50                                 
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 15                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED BY USING STANDARD 2D           
REMARK 210  HOMONUCLEAR TECHNIQUES                                              
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS                                             
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   O    ALA B    12     H    TYR B    16              1.52            
REMARK 500   O    ASP B    10     H    ALA B    14              1.53            
REMARK 500   O    CYS B    19     H    ARG B    22              1.57            
REMARK 500   O    SER B     9     H    GLU B    13              1.59            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 VAL B   2     -151.43    -91.60                                   
REMARK 500  1 THR B  27      160.17    -34.69                                   
REMARK 500  2 VAL B   2      -85.16    -47.68                                   
REMARK 500  2 GLN B   4     -143.84   -100.39                                   
REMARK 500  2 GLU B  21       37.94     29.20                                   
REMARK 500  2 THR B  27      154.23    -33.98                                   
REMARK 500  3 VAL B   2      -98.04    -95.75                                   
REMARK 500  3 ASN B   3       53.04   -108.45                                   
REMARK 500  4 LEU A  13      -36.71    -36.47                                   
REMARK 500  4 GLU A  17      -19.34    -49.14                                   
REMARK 500  4 ASN B   3       41.29    177.67                                   
REMARK 500  4 GLN B   4     -169.83   -100.63                                   
REMARK 500  4 THR B  27     -156.96    -96.17                                   
REMARK 500  5 LEU A  13      -38.01    -36.02                                   
REMARK 500  5 GLN B   4     -144.81   -100.42                                   
REMARK 500  5 LYS B  28       72.58   -164.12                                   
REMARK 500  6 VAL B   2      -65.15    -91.11                                   
REMARK 500  6 ASN B   3       51.27   -173.15                                   
REMARK 500  6 GLN B   4     -169.65   -101.56                                   
REMARK 500  6 GLU B  21       28.80     37.28                                   
REMARK 500  6 THR B  27     -156.69    -59.97                                   
REMARK 500  7 VAL B   2     -179.63    -62.08                                   
REMARK 500  7 ASN B   3       73.01    -65.30                                   
REMARK 500  7 LYS B  28      101.32     62.27                                   
REMARK 500  8 LEU A  13      -35.04    -34.36                                   
REMARK 500  8 TYR A  19       43.99   -141.11                                   
REMARK 500  8 VAL B   2     -166.89    -59.31                                   
REMARK 500  8 ASN B   3       50.60    -97.55                                   
REMARK 500  8 GLN B   4     -168.56   -101.05                                   
REMARK 500  8 SER B   9      -73.46    -38.45                                   
REMARK 500  8 CYS B  19      -62.85    -98.30                                   
REMARK 500  8 GLU B  21       28.47     39.66                                   
REMARK 500  8 THR B  27      171.75    -41.87                                   
REMARK 500  8 LYS B  28       70.47     73.18                                   
REMARK 500  9 LEU A  13      -33.19    -34.54                                   
REMARK 500  9 ASN B   3       35.33    177.67                                   
REMARK 500  9 SER B   9      -71.81    -37.30                                   
REMARK 500  9 THR B  27     -152.95    -82.10                                   
REMARK 500  9 LYS B  28      124.86    -39.95                                   
REMARK 500 10 TYR A  19       38.66   -140.28                                   
REMARK 500 10 ASN B   3       49.48   -158.28                                   
REMARK 500 10 GLN B   4     -164.35   -100.94                                   
REMARK 500 10 LYS B  28       83.67   -164.85                                   
REMARK 500 11 VAL B   2     -155.66    -75.07                                   
REMARK 500 11 ASN B   3       55.01   -174.32                                   
REMARK 500 11 GLN B   4     -151.92   -100.23                                   
REMARK 500 11 SER B   9      -71.87    -39.28                                   
REMARK 500 11 GLU B  21       22.92     38.07                                   
REMARK 500 11 THR B  27      147.99    -27.62                                   
REMARK 500 12 VAL B   2      -91.33    -46.21                                   
REMARK 500                                                                      
REMARK 500 THIS ENTRY HAS      63 RAMACHANDRAN OUTLIERS.                        
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: PLANAR GROUPS                                              
REMARK 500                                                                      
REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL                 
REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE                    
REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN                    
REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS                        
REMARK 500 AN RMSD GREATER THAN THIS VALUE                                      
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        RMS     TYPE                                    
REMARK 500  1 ARG B  22         0.29    SIDE CHAIN                              
REMARK 500  2 ARG B  22         0.30    SIDE CHAIN                              
REMARK 500  3 ARG B  22         0.32    SIDE CHAIN                              
REMARK 500  4 ARG B  22         0.28    SIDE CHAIN                              
REMARK 500  5 ARG B  22         0.22    SIDE CHAIN                              
REMARK 500  6 ARG B  22         0.21    SIDE CHAIN                              
REMARK 500  7 ARG B  22         0.22    SIDE CHAIN                              
REMARK 500  8 ARG B  22         0.26    SIDE CHAIN                              
REMARK 500  9 ARG B  22         0.15    SIDE CHAIN                              
REMARK 500 10 ARG B  22         0.30    SIDE CHAIN                              
REMARK 500 11 ARG B  22         0.30    SIDE CHAIN                              
REMARK 500 12 ARG B  22         0.32    SIDE CHAIN                              
REMARK 500 13 ARG B  22         0.20    SIDE CHAIN                              
REMARK 500 14 ARG B  22         0.23    SIDE CHAIN                              
REMARK 500 15 ARG B  22         0.19    SIDE CHAIN                              
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1LNP   RELATED DB: PDB                                   
REMARK 900 PARENT MOLECULE OF THIS DEPOSITION, CONTAINS THREE SUBSTITUTIONS     
REMARK 900 RELATED ID: 1T1P   RELATED DB: PDB                                   
REMARK 900 THR-B12-DKP-INSULIN                                                  
REMARK 900 RELATED ID: 1T1Q   RELATED DB: PDB                                   
REMARK 900 ABA-B12-DKP-INSULIN                                                  
DBREF  1T1K A    1    21  UNP    P01308   INS_HUMAN       90    110             
DBREF  1T1K B    1    30  UNP    P01308   INS_HUMAN       25     54             
SEQADV 1T1K ASP B   10  UNP  P01308    HIS    34 ENGINEERED MUTATION            
SEQADV 1T1K ALA B   12  UNP  P01308    VAL    36 ENGINEERED MUTATION            
SEQADV 1T1K LYS B   28  UNP  P01308    PRO    52 ENGINEERED MUTATION            
SEQADV 1T1K PRO B   29  UNP  P01308    LYS    53 ENGINEERED MUTATION            
SEQRES   1 A   21  GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU          
SEQRES   2 A   21  TYR GLN LEU GLU ASN TYR CYS ASN                              
SEQRES   1 B   30  PHE VAL ASN GLN HIS LEU CYS GLY SER ASP LEU ALA GLU          
SEQRES   2 B   30  ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR          
SEQRES   3 B   30  THR LYS PRO THR                                              
HELIX    1   1 GLU A    4  SER A    9  1                                   6    
HELIX    2   2 SER A   12  ASN A   18  1                                   7    
HELIX    3   3 CYS B    7  CYS B   19  1                                  13    
SSBOND   1 CYS A    6    CYS A   11                          1555   1555  2.02  
SSBOND   2 CYS A    7    CYS B    7                          1555   1555  2.02  
SSBOND   3 CYS A   20    CYS B   19                          1555   1555  2.02  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000